Глава 7. Терапия антидепрессантами 327

53. Rickels К, Schweizer E, Clary С, et al. Nefazodone and imipramine in major depression: a placebo-con­trolled trial Br J Psychiatry 1994; 164:802-805.

54. Weise C, Fox I, Clary C, et al. Nefazodone in the treatment of outpatient major depression. Biol Psychiatry 1991; 29= 363S.

55. Fawcett J, Marcus R, Anton S, O'Brien K, Schwi-derski U. Response of anxiety and agitation symp­toms during nefazodone treatment of major depression. J Clin Psychiatry 1995; 56 (Suppl 6): 37-42.

56. Musso DL, Mehta NB, Soroko FE, Ferns RM, Holl-ingsworth EB, Kenney ВТ. Synthesis and evalua­tion of the antidepressant activity of the enantio-mers of bupropion. Chirality 1993; 5 (7): 495-500.

57. Pandey GN, Davis JM. Treatment with antidepres-sants, sensitivity of beta receptors and affective illness. New York: John Wiley, 1980.

58. Johnstone EC. The relationship between acetyla-tor status and inhibition of monoamine oxidase, excretion of free drug and antidepressant re­sponse in depressed patients on phenelzine. Psy-chopharmacologia 1976; 46: 289-294.

59. Lecrubies Y, Guelfi JD. Efficacy of reversible in­hibitors of monoamine oxidase-A in various forms of depression. Acta Psychiatr Scand 1990; 360 (Suppl): 18-23.

60. Berwish NJ, Amsterdam JD. An overview of in-vestigational antidepressants. Psychosomatics 1989; 30: 1-17.

61. Greenblatt M, Grosser GH, Wechsler H. Differen­tial response of hospitalized depressed patients to somatic therapy. Am J Psychiatry 1964; 120: 935-943.

62. Quitkin F, Rifkin A, Klein DF. Monoamine oxidase inhibitors: a review of antidepressant effective­ness. Arch Gen Psychiatry 1979; 36: 749-760.

63. Rowan PR, Paykel ES, Parker RR. Phenelzine and amitriptyline: effects on symptoms of neurotic depression. Br J Psychiatry 1982; 140:475-483.

64. Thase ME, Mallinger AG, McKnight D, Himmel-hoch JM. Treatment of imipramine-resistant re­current depression, IV: a double-blind crossover study of tranylcypromine for anergic bipolar depression. Am J Psychiatry 1992; 149:195-198.

65. Wheatley D. Amphetamines in general practice: their use in depression and anxiety. Semin Psy­chiatry 1969; 1:163-173.

66. Hare RH, Dominian J, Sharpe L. Phenelzine and dexamphetamine in depressive illness. Br Med J 1962; 1:9-12.

67. Overall JE, Hollister LE, Pokorny AD, Casey JF, Katz G. Drug therapy in depressions. Clin Phar-macol Ther 1961; 3:16-22.

68. Hesbacher PT. Pemoline and methylphenidate in mildly depressed outpatients. Clin Pharmacol Ther 1970; 11:698-710.

69. Rickels K, Ginrich RL Jr, McLaughlin W, et al. Methylphenidate in mildly depressed outpatients. Clin Pharmacol Ther 1972; 13: 595-601.

70. Robin AA, Wiseberg S. A controlled trial of methy­lphenidate (Ritalin) in the treatment of depres­sive states. J Neural Neurosurg Psychiatry 1958; 21: 55-57.

71. Kaplitz SE. Withdrawn apathetic geriatric patients responsive to methylphenidate. J Am Geriatr Soc 1975: 23: 271-276.

72. Mendels J, Ramsey ТА, Dyson WL, Frazer A. Lithi­um as an antidepressant. Arch Gen Psychiatry 1979; 36: 845-846.

73. Souza FGM, Goodwin GM. Lithium treatment and prophylaxis in unipolar depression: a meta-ana-lysis. Br J Psychiatry 1991; 158:666-675.

74. Hollister LE, Overall JE, Shelton J, Pennington V, Kimbell I, Johnson M. Drug therapy of depression. Amitriptyline, perphenazine, and their combina­tion in different syndromes. Arch Gen Psychiatry 1967; 17: 486-493-

75. Overall JE, Hollister LE, Meyer F, Kimball I Jr, Shel­ton J. Imipramine and thioridazine in depressed and schizophrenic patients. Are there specific antidepressant drugs? JAMA 1964; 189:605-608.

76. Lesser IM. The relationship between panic disor­der and depression. J Anxiety Disord 1988; 2: 2-16.

77. Lesser IM, Rubin RT, Pecknold JC, et al. Second­ary depression in panic disorder and agorapho­bia. I. Frequency, severity, and response to treat­ment. Arch Gen Psychiatry 1988; 45:437-443.

78. Grunhaus L, Harel Y, Krugler T, Pande AC, Has-kett RF. Major depressive disorder and panic dis­order. Clin Neuropharmacol 1988; 11:454-461.

79. Lesser IM. The treatment of panic disorders: pharmacologic aspects. Psychiatr Ann 1991; 21: 341-346.

80. Keller MB, Lavori PW, Goldenberg IM, et al. In­fluence of depression on the treatment of panic disorder with imipramine, alprazolam and place­bo. J Affective Disord 1993; 28 (1): 27-38.

81. Schatzberg AF, Cole JO. Benzodiazepines in de­pressive disorders. Arch Gen Psychiatry 1978; 24: 509-514.